Open Medicine: Rethinking the Translational Research for the -omic Era

The integration of informatics, social networking, biobanking/biotechnology and clinical medicine is poised to deliver new translational targets for diagnostic and therapeutic questions in clinical medicine. Clinical medicine and research have steadily separated themselves over the past few decades.

Creating a novel model to harvest community-based clinical practice and harness it for translational research purposes bring clinical practice and research closer together in a practical manner, enabling rethinking of poorly defined diseases and refocusing clinicians on better defined outcomes for any disease - a grand step towards better personalized medicine.

Building a collaborative network involving community clinicians, hospitals, academics, and industry partners is key to the success of this model. Impact of this network to date in practice settings and collaborative environments will be discussed as well as future directions

Speaker Bio

Dr. Andreas M. Kogelnik, is the founding Director of the Open Medicine Institute. Dr. Kogelnik received his M.D. from Emory University School of Medicine in Atlanta and his Ph.D. in Bioengineering from the Georgia Institute of Technology. Subsequently, he completed his residency in Internal Medicine and a Fellowship in Infectious Diseases at Stanford University and its affiliated hospitals.

Following his clinical training, he remained at Stanford with NIH funding for his post-doctoral research in microbiology, immunology and bioinformatics with Dr. Ellen Jo Baron and Dr. Stanley Falkow, where he explored molecular host-expression profiles in a variety of diseases as well as with Dr. Atul Butte on large scale data mining of clinical and research data. Apart from Stanford he has worked with a variety of biotech, molecular diagnostic, pharma, and informatics companies and has started three companies and one non-profit in the medical space.

He has led numerous efforts to integrate clinical and research databases and is the author of numerous papers and book chapters. He is an Editor of Computers in Biology and Medicine.

Topic: “Open Medicine: Rethinking the Translational Research for the -omic Era”
Speaker: Dr. Andreas M. Kogelnik, founding Director of the Open Medicine Institute
Date and Time: Thursday September 1, 2011, 6:00 - 9:00 pm, presentation begins at 6:45 pm
Location: Triple Ring Technologies, 39655 Eureka Dr. Newark
Cost: The seminar is free of charge, but registration is required for planning purposes
On-Site registration: A limited number of on-site registrations will be available. For more information and registration visit
http://www.medtechfrontiers.com
Topic Description